Drake Thomas, another Anthropic employee, stated that he respects Coxon's choice to refrain from building these models if he fears they could pose planetary-scale risks. "Things are moving too fast; ...
A critical point, at this stage, is the failure by Revolution Medicines to activate an expanded access program, which would allow early access to the drug,” remarks Chiara Cremolini, a member of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results